175 filings
Page 3 of 9
CORRESP
78lpy1q53lbe
20 Oct 22
Correspondence with SEC
12:00am
UPLOAD
yqghvxpizhhidj4a46
20 Oct 22
Letter from SEC
12:00am
8-K
jofewdi zr
19 Oct 22
Material Modifications to Rights of Security Holders
5:06pm
8-K
uuf 3dx75
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
424B5
t7ff7wl
19 Aug 22
Prospectus supplement for primary offering
8:42am
8-K
9ac8h0
19 Aug 22
Other Events
8:39am
424B5
z7pv jj6u
19 Aug 22
Prospectus supplement for primary offering
8:37am
FWP
c52yjcnmq ed6
17 Aug 22
Free writing prospectus
5:15pm
424B5
4wusgu
16 Aug 22
Prospectus supplement for primary offering
5:26pm
8-K
rc08jf33z33f9j
12 Aug 22
UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:18am
8-K
5rdovj b3
12 Aug 22
UNITY Biotechnology, Inc. Reports Second Quarter 2022
7:15am
8-K
xplupa7 nuatd0
5 Jul 22
Other Events
4:01pm
8-K
l6f6l9cxhr38
27 Jun 22
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
nv68f51s5j230pcktzce
7 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
kheyn1k1w0ue49rcrt
26 May 22
UNITY Biotechnology Announces Appointment of Accomplished Finance and Operations Executive Michael Samar to the Board of Directors
9:00am
424B5
8q7b719qq
13 May 22
Prospectus supplement for primary offering
4:18pm